Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma
Open Access
- 15 November 1997
- Vol. 80 (10) , 1966-1972
- https://doi.org/10.1002/(sici)1097-0142(19971115)80:10<1966::aid-cncr14>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989
- Cisplatin, Cyclophosphamide and Doxorubicin Chemotherapy for Unresectable Urothelial Tumors: The M. D. Anderson ExperienceJournal of Urology, 1989
- Chemotherapy of urothelial tract tumorsCancer, 1987
- Phase III Comparison of Cisplatin Alone Versus Cisplatin, Doxorubicin and Cyclophosphamide in the Treatment of Bladder (Urothelial) Cancer: A Southeastern Cancer Study Group TrialJournal of Urology, 1987
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1985
- Cis-Diamminedichloride Platinum II in the Treatment of Abvanced Bladder CancerJournal of Urology, 1980
- Cis-Diamminebichloroplatinum as a Therapeutic Agent in Metastatic Transitional Cell CarcinomaJournal of Urology, 1980